Skip to main content
SOMNOMED LIMITED logo

SOMNOMED LIMITED — Investor Relations & Filings

Ticker · SOM ISIN · AU000000SOM1 LEI · 529900NFR8QFOLJGP577 ASX Manufacturing
Open in API
Filings indexed 982 across all filing types
Latest filing 2025-12-03 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SOM

About SOMNOMED LIMITED

https://somnomed.com

SomnoMed Limited specializes in the development and manufacture of diagnostic and treatment solutions for sleep-related breathing disorders, primarily obstructive sleep apnea (OSA). The company is recognized for its Continuous Open Airway Therapy (COAT), which utilizes custom-fitted oral appliances to maintain an open airway during sleep. Its flagship product line, SomnoDent, offers a range of mandibular advancement devices designed to improve patient compliance and comfort compared to traditional continuous positive airway pressure (CPAP) therapy. SomnoMed focuses on clinical research and technological innovation to provide effective, non-invasive alternatives for patients suffering from mild to moderate OSA and snoring. The company serves a global market, collaborating with sleep dentists and physicians to deliver personalized treatment options that enhance long-term health outcomes and quality of life for individuals with sleep-disordered breathing.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - SOM 8 pages 26.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics about the securities issued, exercise prices, expiry dates, and mentions approval at the Annual General Meeting. The document is a formal notification of securities issuance rather than a full financial report or earnings release. It fits the description of a Share Issue/Capital Change announcement, as it reports on new share options issued and related capital changes. The document length is over 10,000 characters and contains detailed issuance data, confirming it is not a brief announcement or a report publication notice. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2025-12-03 English
Change of Director's Interest Notice 2 pages 267.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares and options held before and after the change, the nature of the interest, and the date of change. This is a clear report of personal share transactions by a company director. The document length is 3393 characters, which is typical for such notices. There is no indication that this is an annual report, earnings release, or any other type of financial or regulatory report. Therefore, the document fits the definition of Director's Dealing (DIRS).
2025-12-03 English
Change of Director's Interest Notice 2 pages 266.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares and options held before and after the change, the nature of the change, and dates. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial performance data, earnings, or management discussion, nor is it an announcement of a report publication. Therefore, it fits the definition of 'Director's Dealing' filings.
2025-12-03 English
AGM Investor Presentation & addresses 12 pages 788.1KB
AGM Information Classification · 95% confidence The document is titled 'Annual General Meeting 2025' and contains detailed presentations and addresses from the Chairman and Co-CEOs during the AGM. It includes financial highlights, operational updates, strategic outlook, leadership changes, and product development progress. The content is consistent with materials typically shared during an Annual General Meeting, focusing on summarizing the company's performance, strategy, and leadership messages to shareholders. There is no indication that this is a full Annual Report (10-K) or an Earnings Release (ER), nor is it a simple announcement or certification. The length and detail support it being AGM presentation materials rather than a brief announcement or regulatory filing. Therefore, the document fits the category of AGM Information (AGM-R).
2025-11-26 English
AGM results 2 pages 248.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 27th November 2025 reporting the results of the Annual General Meeting (AGM) of SomnoMed Limited held on the same day. It details the voting outcomes for various resolutions, including adoption of the remuneration report, election and re-election of directors, and issue of options. The document includes proxy votes and poll results as required by the Corporations Act 2001 and ASX Listing Rules. The content is focused on the official voting results from the AGM, not the AGM materials or presentations themselves. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3233 characters, which is consistent with a voting results announcement rather than a full AGM presentation or report.
2025-11-26 English
Quarterly Update 2 pages 205.8KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Q1 FY26 Quarterly Update' and provides detailed financial and operational information for the quarter ended 30 September 2025. It includes revenue figures, regional breakdowns, cash balance, and guidance for the full fiscal year. The content is substantive and contains actual financial data and analysis for a period shorter than a full fiscal year, which fits the definition of an Interim / Quarterly Report (IR). The document is 4163 characters long, which is relatively short but contains detailed financial data, not just an announcement or summary. Therefore, it is classified as an Interim / Quarterly Report (IR). Q1 2026
2025-10-29 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.